medigraphic.com
Academia Mexicana de Neurología, A.C.

2019, Number 2

<< Back Next >>

Rev Mex Neuroci 2019; 20 (2)

Clinical guideline: epilepsy in pregnancy and women of childbearing age

González-Vargas PO, Matuk-Pérez Y, Sosa Hernández JL, Quiñones-Canales G, Silva-Sánchez SE, Aguayo-Leytte G, Medina-Benitez S, Ibarra-Puig JM, Loy-Gerala MC, Castro-Martínez E

Language: English
References: 24
Page: 104-109
PDF size: 101.60 Kb.


ABSTRACT

Childbearing-aged and pregnant women undergo physiological modifications that make them think in a particular way about epilepsy and the management of taking antiepileptic drugs. These guidelines address both the effects of epilepsy in the gynecological, obstetric, and perinatal aspect of the woman, with a series of recommendations based on evidence-based medicine.


REFERENCES

  1. Instituto Nacional de Estadística y Geografía. Población; 2015. https:// www.inegi.org.mx/temas/estructura. [Last accessed 2018 May].

  2. Yang Y, Wang X. Sexual dysfunction related to antiepileptic drugs in patients with epilepsy. Expert Opin Drug Saf. 2016;15:31-42.

  3. Harden CL, Pennell PB. Neuroendocrine considerations in the treatment of men and women with epilepsy. Lancet Neurol. 2013;12:72-83.

  4. Mandle HB, Cahill KE, Fowler KM, et al. Reasons for discontinuation of reversible contraceptive methods by women with epilepsy. Epilepsia. 2017;58:907-14.

  5. Espinera AR, Gavvala J, Bellinski I, et al. Counseling by epileptologists affects contraceptive choices of women with epilepsy. Epilepsy Behav. 2016;65:1-6.

  6. Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsy focus on pregnancy (an evidence- based review): Obstetrical complications and change in seizure frequency: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American academy of neurology and American epilepsy society. Neurology. 2009;73:126-32.

  7. Gerard EE, Meador KJ. Managing epilepsy in women. Continuum (Minneap Minn). 2016;22:204-26.

  8. Bromley RL, Baker GA. Fetal antiepileptic drug exposure and cognitive outcomes. Seizure. 2017; 44:225-31.

  9. Tomson T, Battino D, Bonizzoni E, et al. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP. Epilepsia. 2016;57:e173-7.

  10. Herzog AG, Mandle HB, Cahill KE, Fowler KM, Hauser WA. Predictors of unintended pregnancy in women with epilepsy. Neurology. 2017; 88:728-33.

  11. Roberts JI, Metcalfe A, Abdulla F, et al. Neurologists‘ and neurology residents‘ knowledge of issues related to pregnancy for women with epilepsy. Epilepsy Behav. 2011;22:358-63.

  12. Tomson T, Xue H, Battino D. Major congenital malformations in children of women with epilepsy. Seizure. 2015;28:46-50.

  13. Bollig KJ, Jackson DL. Seizures in pregnancy. Obstet Gynecol Clin North Am. 2018;45:349-67.

  14. Aya AG, Ondze B, Ripart J, Cuvillon P. Seizures in the peripartum period: epidemiology, diagnosis and management. Anaesth Crit Care Pain Med. 2016;35 Suppl 1:S13-S21.

  15. Vajda FJ, Hitchcock A, Graham J, et al. Seizure control in antiepileptic drug-treated pregnancy. Epilepsia. 2008;49:172-6.

  16. Razaz N, Tomson T, Wikström AK, Cnattingius S. Association between pregnancy and perinatal outcomes among women with epilepsy. JAMA Neurol. 2017;74:983-91.

  17. MacDonald SC, Bateman BT, McElrath TF, Hernández-Díaz S. Mortality and morbidity during delivery hospitalization among pregnant women with epilepsy in the United States. JAMA Neurol. 2015;72:981-8.

  18. González-Vargas PO, Savery D, Gerrelli D. Defectos del tubo neural. Experiencia en un hospital de Toluca, México. Arch Neurocien (Mex) 2007;12:171-5.

  19. Ban L, Fleming KM, Doyle P, et al. Congenital anomalies in children of mothers taking antiepileptic drugs with and without periconceptional high dose folic acid use: a population-based cohort study. PLoS One. 2015;10:e131130.

  20. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Folic acid supplementation for the prevention of neural tube defects: US preventive services task force recommendation statement. JAMA 2017;317:183-9.

  21. Kaaja E, Kaaja R, Matila R, Hiilesmaa V. Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate. Neurology. 2002;58:549-53.

  22. Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: report of the quality standards subcommittee and therapeutics and technology assessment subcommittee of the American academy of neurology and American epilepsy society. Neurology. 2009;73:133-41.

  23. Veiby G, Bjørk M, Engelsen BA, Gilhus NE. Epilepsy and recommendations for breastfeeding. Seizure. 2015;28:57-65.

  24. Lavi-Blau T, Ekstein D, Neufeld MY, Eyal S. Use of antiepileptic drugs during pregnancy and lactation: type of information provided by searching google. Epilepsy Behav. 2016;55:113-9.




2020     |     www.medigraphic.com